Here's a list of top 7 stocks in news on the back of big deals, quarterly earnings.
SKS Microfinance Limited, has witnessed a 49.5 percent increase in its net profit to Rs 40.53 crore for the fourth quarter ended March 2015, as compared with Rs 27.11 crore in the corresponding quarter of the previous year.
Its total income stood at Rs 226.2 crore, during the quarter under review, as against Rs 147.37 crore, reflecting a growth of 53.49 percent . SKS Micrifinance Limited's scrip ended the trade at Rs 463.60 on the BSE on Monday, down 1.26percent , over the previous close of Rs 469.50 a share.
Mangalam Cement Ltd has announced the following results for the quarter & year ended March 31, 2015. The company reported net profit of Rs. 2.7 crore in Q4 FY15 against Rs. 7.7 crore in the same period last quarter. During the period under review, the company's total Income stood at Rs. 238.7 crore versus Rs. 218.4 crore year on year. The company sales increased to Rs. 235 crore in Q4 FY15 compared to Rs. 213 crore in Q4 FY14. The company has recommended dividend of Rs. 2/- per share for the year ended March 31, 2015.
Cognizant sees a good show in quarter 1 in CY15 on quarter on quarter. USD revenue growth of 6.2 percent. It has beats estimates and company has its own guidance. CY15 USD revenue guidance upped to at least 19.3 percent from at least 19 percent. Guidance upped 3 months into calendar year. CY15 EPS guidance also upped by 0.6 percent. Results provide comfort after a disappointing print by IT company in March quarter.
Can Fin Homes has a good quarter 4 in FY15 on year on year. Total Income down by 40 percent at Rs 227 crore versus Rs 161.7 crore. Calculated Net Interest Income down by 50 percent at Rs 59.3 crore versus Rs 39.5 crore. Profit down by 14 percent at Rs 22.88 crore versus Rs 20.11 crore. Taxes at Rs 16.4 crore versus Rs 7.8 crore.
DLF plans to raise its fund. Company to launch Rs 3,600 crore CMBS issue. CMBS has commercial mortgage backed securities. To launch CMBS in next 2 months, backed by IT-SEZ. Part of strategy to replace costlier debt. To launch first REITs to monetize commercial assets. Comapny net debt stood at Rs 20,336 crore.
JPMorgan says Future and Bharti Deal has improved geographic reach, particularly in North India. Deal may lead to synergies, cost savings on front & backends. The concerns is Macro headwinds, high leverage and Poor working capital efficiency. FRL needs to de-leverage balance sheet further. FRL may see lower profitability levels in coming qtrs if BS not deleveraged. Value retail biz at 20x forward P/E.
Sun Pharma Credit Suisse on Taro Brokerages. Maintain outperform brokerages on Taro. Taro has pushed through price increase in 2 products. Taro has increased prices on Enalapril Maleate which treats high blood pressure. Taro increased prices on Econazole which is anti-fungal medication. Both drugs together could add incremental sales of USD 20-25 million. Can boost Taro's current run rate of sales by 3percent , EBITDA by 4 percent.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
